Federal Policymakers Should Urgently and Greatly Expand Naloxone Access.
作者信息
Jawa Raagini, Murray Stephen, Tori Marco, Bratberg Jeffrey, Walley Alexander
机构信息
Raagini Jawa is with the Grayken Center for Addiction and Clinical Addiction Research and Education Unit, Section of General Internal Medicine and the Section of Infectious Disease, Department of Medicine, Boston University School of Medicine, Boston, MA. Stephen Murray is with the Clinical Addiction Research and Education Unit, Section of General Internal Medicine, Department of Medicine, Boston University School of Medicine and a trainee at Boston University School of Public Health. Marco Tori is with the Division of General Internal Medicine, Boston University School of Medicine. Jeffrey Bratberg is with the College of Pharmacy, University of Rhode Island, Kingston. Alexander Walley is with the Grayken Center for Addiction and with Clinical Addiction Research and Education Unit, Boston University School of Medicine.
出版信息
Am J Public Health. 2022 Apr;112(4):558-561. doi: 10.2105/AJPH.2021.306699.
Abstract
摘要
相似文献
1
Federal Policymakers Should Urgently and Greatly Expand Naloxone Access.联邦政策制定者应立即大幅扩大纳洛酮的可及性。
Am J Public Health. 2022 Apr;112(4):558-561. doi: 10.2105/AJPH.2021.306699.
2
3
Naloxone Access and Use for Suspected Opioid Overdoses.纳洛酮用于疑似阿片类药物过量的获取与使用。
Ann Emerg Med. 2017 Jul;70(1):112-113. doi: 10.1016/j.annemergmed.2017.03.031.
4
Can Naloxone Be Used to Treat Synthetic Cannabinoid Overdose?纳洛酮可用于治疗合成大麻素过量吗？
Biol Psychiatry. 2017 Apr 1;81(7):e51-e52. doi: 10.1016/j.biopsych.2016.08.013. Epub 2016 Aug 18.
5
Naloxone Conundrum: Reduce risk in managing the opioid overdose patient.纳洛酮难题：降低阿片类药物过量患者管理中的风险。
JEMS. 2016 Nov;41(11):14-5.
6
Lessons from a naloxone kit.来自纳洛酮试剂盒的经验教训。
CMAJ. 2019 Sep 23;191(38):E1059-E1060. doi: 10.1503/cmaj.190446.
7
Should we worry that take-home naloxone availability may increase opioid use?我们是否应该担心可带回家的纳洛酮的可得性可能会增加阿片类药物的使用？
Addiction. 2019 Oct;114(10):1723-1725. doi: 10.1111/add.14637. Epub 2019 Jun 12.
8
Take-home emergency naloxone to prevent deaths from heroin overdose.携带式急救纳洛酮可预防海洛因过量致死。
BMJ. 2014 Nov 4;349:g6580. doi: 10.1136/bmj.g6580.
9
Overdose reversal.
Am J Nurs. 2015 Jan;115(1):13. doi: 10.1097/01.NAJ.0000459609.86788.ac.
10
Take-home naloxone in Australia and beyond.澳大利亚及其他地区的纳洛酮带回家计划。
Drug Alcohol Rev. 2018 May;37(4):437-439. doi: 10.1111/dar.12700.
引用本文的文献
1
Longitudinal evaluation examining implementation and sustainment of an opioid overdose education and naloxone distribution among veterans who are unstably housed.对不稳定住房的退伍军人进行阿片类药物过量教育和纳洛酮分发的实施与维持情况的纵向评估。
Implement Sci Commun. 2025 Aug 6;6(1):83. doi: 10.1186/s43058-025-00764-3.
2
Effectiveness of naloxone distribution in community settings to reduce opioid overdose deaths among people who use drugs: a systematic review and meta-analysis.社区环境中纳洛酮分发在减少吸毒者阿片类药物过量死亡方面的有效性：一项系统评价和荟萃分析。
BMC Public Health. 2025 Mar 25;25(1):1135. doi: 10.1186/s12889-025-22210-8.
3
Scaling up overdose education and naloxone distribution in Kentucky: adoption and reach achieved through a "hub with many spokes" model.在肯塔基州扩大过量用药教育和纳洛酮分发规模：通过“多中心辐射”模式实现的采用和覆盖范围。
Addict Sci Clin Pract. 2023 Nov 30;18(1):72. doi: 10.1186/s13722-023-00426-6.
4
Current and emerging pharmacotherapies for opioid dependence treatments in adults: a comprehensive update.成人阿片类药物依赖治疗的现有和新兴药物治疗方法：全面更新。
Expert Opin Pharmacother. 2022 Nov;23(16):1819-1830. doi: 10.1080/14656566.2022.2140039. Epub 2022 Nov 14.
5
Responding to a surge in overdose deaths: perspectives from US syringe services programs.应对过量死亡激增：来自美国注射器具服务项目的观点。
Harm Reduct J. 2022 Jul 19;19(1):79. doi: 10.1186/s12954-022-00664-y.
本文引用的文献
1
Targeting community-based naloxone distribution using opioid overdose death rates: A descriptive analysis of naloxone rescue kits and opioid overdose deaths in Massachusetts and Rhode Island.利用阿片类药物过量死亡率为社区提供纳洛酮：马萨诸塞州和罗得岛州纳洛酮急救包和阿片类药物过量死亡的描述性分析。
Int J Drug Policy. 2021 Dec;98:103435. doi: 10.1016/j.drugpo.2021.103435. Epub 2021 Sep 3.
2
FDA Initiative for Drug Facts Label for Over-the-Counter Naloxone.FDA 倡议为非处方纳洛酮药物事实标签。
N Engl J Med. 2020 May 28;382(22):2129-2136. doi: 10.1056/NEJMsa1912403.
3
Laws Mandating Coprescription of Naloxone and Their Impact on Naloxone Prescription in Five US States, 2014-2018.法规要求联合开具纳洛酮处方及其对 2014-2018 年美国五个州纳洛酮处方的影响。
Am J Public Health. 2020 Jun;110(6):881-887. doi: 10.2105/AJPH.2020.305620. Epub 2020 Apr 16.
4
Vital Signs: Pharmacy-Based Naloxone Dispensing - United States, 2012-2018.生命体征：2012-2018 年美国基于药房的纳洛酮配药情况。
MMWR Morb Mortal Wkly Rep. 2019 Aug 9;68(31):679-686. doi: 10.15585/mmwr.mm6831e1.
5
Association of Naloxone Coprescription Laws With Naloxone Prescription Dispensing in the United States.纳洛酮共开处方法律与美国纳洛酮处方配药的关联。
JAMA Netw Open. 2019 Jun 5;2(6):e196215. doi: 10.1001/jamanetworkopen.2019.6215.
6
Opioid Overdose Prevention Programs Providing Naloxone to Laypersons - United States, 2014.2014年美国向非专业人员提供纳洛酮的阿片类药物过量预防项目
MMWR Morb Mortal Wkly Rep. 2015 Jun 19;64(23):631-5.
7
Review of naloxone safety for opioid overdose: practical considerations for new technology and expanded public access.阿片类药物过量使用时纳洛酮安全性综述：新技术与扩大公众可及性的实际考量
Ther Adv Drug Saf. 2015 Feb;6(1):20-31. doi: 10.1177/2042098614564776.
Zotero 插件